L1CAM and neoplasm: Although we cannot change our current practice, this finding is of clinical relevance since patients with p53wt/L1CAMpos could receive more aggressive adjuvant treatment like p53ab tumours, as well it could also be attractive to develop anti-L1CAM target therapies.